The antihistoplasma activity of recombinant murine gamma interferon (rMuIFN--y)-treated macrophages of the RAW 264.7 cell line depends on the generation of nitric oxide (NO) from L-arginine. Macrophages of the P388D, cell line treated with rMuIFN-y do not produce NO-or inhibit the intracellular growth of Histoplasma capsulatum. NO is generated by the inducible enzyme nitric oxide synthase (iNOS) formed by stimulated macrophages. Northern (RNA) blot analysis of RAW 264.7 cells revealed the expression of iNOS mRNA after exposure to rMuIFN-y. In contrast, rMuIFN-,y-treated P388D1 cells did not produce detectable levels of iNOS. These data suggest that the failure of P388D1 cells to generate NO and to restrict the intracellular growth of H. capsulatum is due to a lack of expression of iNOS following treatment with rMuIFN--y.
The dimorphic fungus Histoplasma capsulatum is a facultative intracellular pathogen of the mononuclear phagocyte system of susceptible animals. Gamma interferon (IFN--y) plays a key role in host defense against histoplasmosis. Treatment of normal mouse peritoneal macrophages with recombinant murine IFN-y (rMuIFN-y) inhibits the intracellular growth of H. capsulatum (12) . In contrast, resident red pulp splenic macrophages require a double signal (e.g., rMuIFN--y and lipopolysaccharide [LPS] ) in order to be fully activated to the antihistoplasma state (7) . It has recently been shown that treatment of the mouse macrophage-like cell line RAW 264. 7 with rMuIFN-,y inhibits the intracellular growth of H. capsulatum (10) .
Macrophages contain the immunologically inducible enzyme nitric oxide synthase (iNOS) (8) . Appropriately stimulated macrophages produce iNOS, which cleaves the guanidino nitrogen group from L-arginine to generate NO and L-citrulline (9) . The production of NO-by macrophages represents a key defense mechanism against some obligate and facultative intracellular pathogens (1, 4, 6) . Treatment of RAW 264.7 cells with rMuIFN--y results in the production of NO which correlates with the antihistoplasma activity of the cells (10) . However, P388D, macrophages do not restrict the intracellular growth of H. capsulatum following treatment with rMuIFN-,y alone or in combination with LPS (13) . The " Determined from supernatants of the macrophage monolayers at the completion of the experiment by using methods previously described (2, 3).
NotI, and the 4,100-bp iNOS cDNA fragment was isolated by gel electrophoresis. Total RNA was isolated from RAW 264.7 and P388D, cells by using the Total RNA Isolation System kit (Promega, Madison, Wis.). Northern (RNA) blot analysis of total RNA was performed according to standard techniques by using the 32P-labeled iNOS cDNA as a probe (11). Nakamura et al. (10) have shown that macrophages of the RAW 264.7 cell line produces NO2-which correlates with activation to an antihistoplasma state. The data in Table I show that treatment of P388D, macrophages with rMuIFN-y (5,000 U/ml) resulted in the production of only baseline levels of NO2-and no inhibition of growth of the fungus. In contrast, high levels of NO2-(24.4 ± 0.4 pLM) were produced by activated RAW 264.7 cells, which correlated well with the induced fungistasis. Following an 18-h incubation period, total RNA was isolated from macrophages exposed to rMuIFN-y or SMEM alone. Northern blot analysis of rMuIFN-y-treated RAW 264.7 cells probed with iNOS cDNA showed that these cells produced a 4.1-kb band corresponding to the iNOS mRNA ( Fig. 1) 3) rMuIFN-y. Total RNA was isolated for both RAW 264.7 (10 ,ug) and P388D1 (20 ,ug) cells, electrophoresed on an agarose-formaldehyde gel, and hybridized with 32P-labeled iNOS cDNA. only (Fig. 1) . iNOS mRNA was not detected from P388D, cells treated with either rMuIFN-y or medium alone, even though twice as much RNA was loaded into the lanes compared with the amount loaded for RAW 264.7 macrophages (Fig. 1) . The inability of rMuIFN-y-treated P388D, to produce detectable levels of iNOS corresponds with their failure to release NO- (Table 1 ). These data provide one possible explanation for the failure of P388D1 cells to be activated to an antihistoplasma state in response to rMuIFN-y. We thank Genentech Inc., South San Francisco, Calif., for the supply of rMuIFN-y. We thank Marcia Trylch for help in preparation of the manuscript.
